EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Symptoms before and after COVID-19: a population and case–control study using prospective data

Carole H Sudre, Michela Antonelli, Nathan J Cheetham, Erika Molteni, Liane S Canas, Vicky Bowyer, Ben Murray, Khaled Rjoob, Marc Modat, Joan Capdevila Pujol, Christina Hu, Jonathan Wolf und 5 weitere

European Respiratory Journal · 2024

DOI: 10.1183/13993003.01853-2023 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Respiratory Journal, 2024. Verfasst von Carole H Sudre und 16 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Wellcome Trust, Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Some individuals experience prolonged illness after acute coronavirus disease 2019 (COVID-19). We assessed whether pre-infection symptoms affected post-acute COVID illness duration.

Methods

Survival analysis was performed in adults (n=23 452) with community-managed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection prospectively self-logging data through the ZOE COVID Symptom Study app, at least weekly, from 8 weeks before to 12 weeks after COVID-19 onset, conditioned on presence versus absence of baseline symptoms (4–8 weeks before COVID-19). A case–control study was performed in 1350 individuals with long illness (≥8 weeks, including 906 individuals (67.1%) with illness ≥12 weeks), matched 1:1 (for age, sex, body mass index, testing week, prior infection, vaccination, smoking, index of multiple deprivation) with 1350 individuals with short illness (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19SARS-CoV-2HumansFemaleMaleCase-Control StudiesMiddle AgedProspective StudiesAdultAgedTime FactorsPost-Acute COVID-19 SyndromeSurvival AnalysisFatigue

Autor:innen und Institutionen

  • School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK.
  • MRC Unit for Lifelong Health and Ageing at UCL, Department of Population Science and Experimental Medicine, University College London, London, UK.
  • Centre for Medical Image Computing, Department of Computer Science, University College London, London, UK.
  • Department of Twin Research and Genetic Epidemiology, School of Life Course and Population Sciences, King's College London, London, UK.
  • ZOE Limited London, London, UK.
  • Guy's and St Thomas' PET Centre, Guy's and St Thomas' NHS Foundation Trust, London, UK.

Förderung

  • Wellcome Trust
  • Medical Research Council

Zitieren

APA

Sudre, C. H., Antonelli, M., Cheetham, N. J., Molteni, E., Canas, L. S., Bowyer, V., Murray, B., Rjoob, K., Modat, M., Capdevila Pujol, J., Hu, C., Wolf, J., Spector, T. D., Hammers, A., Steves, C. J., Ourselin, S., & Duncan, E. L. (2024). Symptoms before and after COVID-19: a population and case–control study using prospective data. European Respiratory Journal. https://doi.org/10.1183/13993003.01853-2023

Vancouver

Sudre CH, Antonelli M, Cheetham NJ, Molteni E, Canas LS, Bowyer V, et al. Symptoms before and after COVID-19: a population and case–control study using prospective data. European Respiratory Journal. 2024. doi:10.1183/13993003.01853-2023

BibTeX
@article{Sudre2024,
  author = {Sudre, Carole H and Antonelli, Michela and Cheetham, Nathan J and Molteni, Erika and Canas, Liane S and Bowyer, Vicky and Murray, Ben and Rjoob, Khaled and Modat, Marc and Capdevila Pujol, Joan and Hu, Christina and Wolf, Jonathan and Spector, Tim D and Hammers, Alexander and Steves, Claire J and Ourselin, Sebastien and Duncan, Emma L},
  title = {Symptoms before and after COVID-19: a population and case–control study using prospective data},
  journal = {European Respiratory Journal},
  year = {2024},
  doi = {10.1183/13993003.01853-2023}
}
Kostenlos starten →